Skip to main content
Equibles
CNXC logo

CNXC · Concentrix Corp · Metrics

Track CNXC — free

Use CNXC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CNXC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$32.64 -1.61 (-4.70%)
Ex-dividend: $0.37 · Oct 23, 2026 Return incl. dividend (before tax) -3.62%
S&P 600 member Russell 2000 member Rebalance outlook locked
Customer concentration — top 5 customers 19% of revenue

5 customers — 19% of revenue (fiscal year 2025)

“Our five largest clients collectively represented approximately 19% of our revenue in fiscal year 2025.”

5 customers — 19% of receivables (November 30, 2025)

“approximately 19% of our accounts receivable balance as of November 30, 2025 was attributable to five clients.”
View the 10-K filed Jan 28, 2026
Market Cap
$2.09B
Shares
61.11M
Volume · Oct 23 796.87K Avg daily vol (3M) 1.54M

CNXC metrics

98 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$34.25
Market cap
$2.09B

Price action

20 metrics
Price change (1W)
+23.8%
Price change (30D)
+12.3%
Price change (3M)
+56.1%
Price change (6M)
+27.9%
Price change (YTD)
-17.6%
Price change (1Y)
-27.6%
Trailing year
Price change (5Y)
-81.5%
52-week high
$47.59
52-week low
$20.97
Change from 52-week high
-28.0%
Change from 52-week low
+63.3%
Annualized volatility
70.9%
Annualized volatility (3M)
74.5%
Beta
0.8
RSI (14D)
71.1
Price vs SMA 50
+23.8%
Price vs SMA 200
+18.8%
Avg volume (3M)
1.54M
Relative volume
1.1
Average dollar volume
$41.59M

Company

3 metrics
Sector
Technology
Industry
Information Technology Services
Shares outstanding
61.11M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.6×
reciprocal yield 160.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 476.4%
P / book
1.2
reciprocal yield 84.5%
FCF yield
27.5%
TTM · current market cap
Buyback yield
4.7%
P / FCF
3.6
reciprocal yield 27.5%
P / operating cash flow
2.7
reciprocal yield 37.6%
Earnings yield
-114.2%

Historical valuation

8 metrics
P / E historical average (3Y)
14.5×
reciprocal yield 6.9%
P / E historical average (5Y)
15.5×
reciprocal yield 6.4%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 117.6%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 92.7%
EV / EBIT historical average (3Y)
13.0×
reciprocal yield 7.7%
EV / EBIT historical average (5Y)
13.7×
reciprocal yield 7.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
4.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
9.2%
Dividend / share (TTM)
$1.44
Dividend growth YoY
+8.1%
Dividend growth streak
4
Last ex-dividend
2026-07-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-29

Profitability

9 metrics
Gross margin
34.1%
Operating margin
-20.9%
Trailing 12 months
Net margin
-24.0%
Gross profit (TTM)
$3.40B
Operating profit (TTM)
−$2.08B
Net income (TTM)
−$2.39B
Trailing 12 months
Diluted EPS (TTM)
$-38.42
FCF margin
5.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$162.79
Gross profit per diluted share (TTM)
$55.48
Operating profit per diluted share (TTM)
$-33.78
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-38.87
Operating cash flow per diluted share (TTM)
$12.85
Free cash flow per diluted share (TTM)
$9.38
Capital expenditures per diluted share (TTM)
$3.46
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.48
Book value per share
$44.45

Growth

11 metrics
Revenue growth YoY
-1.2%
Year over year
Net income growth YoY
-1,221.5%
Revenue (TTM)
$9.97B
Trailing 12 months
EPS growth YoY
-1,311.9%
Shares change YoY
-2.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.8%
Revenue CAGR (5Y)
+15.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+7.5%
FCF CAGR (5Y)
+11.2%

Quality

14 metrics
Return on equity
-135.2%
Return on assets
-25.8%
Debt / equity
2.5
Current ratio
1.2
EBITDA (TTM)
—
Free cash flow (TTM)
$575.01M
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$4.13B
Latest balance sheet
Cash & equivalents
$244.69M
Total assets
$9.26B
Total debt
$4.38B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$787.10M
Capital expenditures (TTM)
$212.09M
R&D (TTM)
—
SG&A (TTM)
$2.90B
Stock compensation (TTM)
$90.50M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
279
13F filer change QoQ
-31
Institutional ownership
114.1%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.6%
Holder tenure
14.4
Price vs estimated holder cost
-59.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.6%

Short interest

3 metrics
Short interest
15.0%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
84 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1803599 CUSIP 20602D101 13F (30d) 48 filings 46 filers Visit website Investor relations